Venture capital firm based in London, UK
AI platform Scindo raises £4m led by Kadmos Capital and Clay Capital. Scindo's enzyme design platform combines AI models and validated reaction data to accelerate enzyme discovery. Read more
OutSee clinches £1.8M in seed funding to boost its AI tool, *Nomaly*, transforming drug discovery and advancing genomic analysis. Read more
GlycanAge secures £3.3 million seed funding to revolutionize personalized preventative healthcare through groundbreaking glycan biomarkers, paving the way for a new era in diagnostics and disease detection. Read more
| Biotech | 60.0% |
| Healthtech | 10.0% |
| AI | 10.0% |
| Greentech | 10.0% |